The mechanism of diminished sodium excretion induced by propranolol was investigated in the dog. Propranolol (0.3 to 5 mg/kg) was given intravenously in a bolus to 16 dogs, eight of which had the renal perfusion pressure controlled by a suprarenal aortic clamp. In another group of six dogs propranolol (0.1 to 5 ,ug/kg/min) was infused into one renal artery for 45 min. Cardiac output (dye dilution), mean arterial and right atrial pressures, heart rate, renal clearances of inulin, creatinine, and para-aminohippurate, and sodium excretion were measured. Total peripheral resistance, central blood volume, stroke volume, renal plasma flow, renal blood flow, renal vascular resistance, glomerular filtration rate, and filtration fraction were calculated.
SUMMARY
The mechanism of diminished sodium excretion induced by propranolol was investigated in the dog. Propranolol (0.3 to 5 mg/kg) was given intravenously in a bolus to 16 dogs, eight of which had the renal perfusion pressure controlled by a suprarenal aortic clamp. In another group of six dogs propranolol (0.1 to 5 ,ug/kg/min) was infused into one renal artery for 45 min. Cardiac output (dye dilution), mean arterial and right atrial pressures, heart rate, renal clearances of inulin, creatinine, and para-aminohippurate, and sodium excretion were measured. Total peripheral resistance, central blood volume, stroke volume, renal plasma flow, renal blood flow, renal vascular resistance, glomerular filtration rate, and filtration fraction were calculated.
Intravenous propranolol resulted in significant decreases in cardiac output (-25%) and heart rate (-14%) and increases in total peripheral resistance (28%) and renal vascular resistance (37%;). Renal blood flow decreased by 25% and filtration fraction increased 21% as urinary sodium excretion diminished 36%. Glomerular filtration did not change significantly. Infusions of propranolol into one renal artery resulted in either no change in sodium excretion or bilateral changes; thus an intrarenal effect of the drug was not demonstrable.
The data suggest that the changes in renal hemodynamics associated with propranolol administration are secondary to alterations in systemic hemodynamics, particularly a decrease in cardiac output. These alterations in renal hemodynamics, including an increase in renal vascular resistance and filtration fraction, most likely account for the decrease in sodium excretion rather than a direct effect of propranolol on sodium reabsorption.
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Beta-adrenergic blockade Renal vascular resistance Sodium excretion Cardiac output Total peripheral resistance Renal blood flow Filtration fraction p ROPRANOLOL is being used in patients with heart disease for the therapy of cardiac arrhythmias, angina pectoris, and hypertension. However, propranolol is known to alter sodium metabolism in normal man and is potentially dangerous in patients with heart disease.' An intact sympathetic nervous system is necessary for normal sodium metabolism. Phenoxybenzamine which blocks the alphaadrenergic receptor, guanethidine which blocks the sympathetic nerve terminals, and renal denervation can cause a decrease in sodium reabsorption which is presumably due to direct effects of sympathetic blockade on the kidney and its circulation.24 However, sympathetic impairment secondary to spinal cord section5-6 and catecholamine depletion7 has in both instances been demonstrated to increase sodium reabsorption. Moreover, in patients with heart disease adrenergic blockade with guanethidine may precipitate overt Circulation, Volume XL1V, heart failure and result in a net decrease in sodium excretion. 8 Since propranolol is now in widespread use, it is important to know whether the drug decreases sodium excretion by a direct intrarenal effect on sodium transport or alternatively by indirectly affecting renal hemodynamics and sodium reabsorption as a result of alterations in systemic hemodynamics.
Methods
Twenty-two experiments were performed in female mongrel dogs weighing 15 to 24 kg. The dogs were allowed water ad libitum and food was withdrawn 18 hours before the experiment, at which time 5 mg of deoxycorticosterone acetate (DOCA) was given intramuscularly. On the day of the experiment the animals were anesthetized with intravenous pentobarbital (30 mg/kg). At least 1 hour prior to the experiment an additional 10 mg DOCA and 2.5 units vasopressin-tannate in oil were injected intramuscularly.
In eight experiments, polyethylene catheters were placed retrograde through a suprapubic incision into the ureters, and through a flank incision into the renal or ovarian vein, and a modified Blalock clamp was placed around the aorta above both renal arteries. In another group of six animals a 25-gauge needle was also placed into one of the renal arteries. In the remaining eight experiments urine was collected from an indwelling urethral catheter. In all experiments, polyethylene catheters were inserted into the inferior vena cava, brachial artery, distal aorta, and right atrium. Pressures in the distal aorta, brachial artery, and right atrium were measured continuously by Sanborn 267 pressure transducers and a direct-writing Hewlett-Packard 7868 recorder.
After the surgical procedures, which required 30 to 60 min, the inulin (50 mg/kg) and/or creatinine prime (50 mg/kg) was administered intravenously and an intravenous infusion of isotonic saline begun at a rate of 0.5 to 1.0 ml/min. The saline infusion contained creatinine or inulin and para-aminohippurate (PAH) sufficient to maintain adequate blood levels for measurement of clearances. Aqueous vasopressin (25 mU/kg/hr) was also added to the maintenance infusion of saline. At least 60 min were allowed from completion of the surgery until the experiment was started. During the experiment urine was collected at 15-min intervals. Arterial and renal venous blood samples were collected at the midpoint of alternate urine collections. Cardiac output (CO) and mean transit time from the right atrium to the Circulation, Volume XLIV, October 1971 distal aorta (MTT) were determined during each 15-min period by the dye-dilution technique using indocyanine green dye, a Gilford 103-IR densitometer, and a Gilford 104 computer. Total peripheral resistance was calculated by (mean brachial artery pressure minus mean right atrial pressure) /CO. Central blood volume was calculated by CO X MTf. Analytical procedures have been described previously.9 Renal plasma flow (RPF) was calculated from the clearance of PAH divided by the renal venous extraction of PAH. Renal blood flow (RBF) was calculated as RPF/ (1 -hematocrit); renal vascular resistance was calculated as mean arterial pressure/RBF; and filtration fraction was calculated as glomerular filtration rate (GFR) / RPF.
Experiments with Intravenous Propranolol Administration
Sixteen experiments were performed in which the effect of the intravenous administration of propranolol on sodium excretion and on renal and systemic hemodynamics was examined. The protocol of the experiments was as follows.
After at least three to five control periods in which the urinary flow rates were stable a dose of 0.3 to 5 mg/kg of propranolol was administered intravenously over 5 min: in two of the experiments the dose of propranolol was 3 mg/kg; in seven experiments the dose was 5 mg/kg; and in seven experiments the dose was 0.3 mg/kg. In four of the animals receiving 5 mg/kg and four of the animals receiving 0.3 mg/kg of propranolol the suprarenal aortic clamp was adjusted to maintain the renal perfusion pressure constant at 110 to 120 mm Hg throughout the experiment. After propranolol administration an additional three to five experimental periods were obtained. Renal venous extractions of PAH were measured in eight animals.
Experiments during the Intrarenal Infusion of Propranolol
In six animals, experiments were performed during the infusion of propranolol into one renal artery (0.1 to 5 ,ug/kg/min) in an effort to detect any direct intrarenal effect of the drug. The same protocol was used in this group of experiments as during the intravenous infusion of the drug, but the cardiac output and renal venous extractions of PAH were not measured.
Results

Intravenous Propranolol Experiments
The effect of intravenous injection of propranolol on systemic hemodynamics is shown in figure 1 experiments in which 0.3 mg/kg of propranolol was administered the mean cardiac output decreased significantly (-25%) as total peripheral resistance increased (30%). Arterial pressure was not significantly changed after this dose of propranolol, but the mean heart rate and stroke volume were significantly decreased (13% and 12%, respectively). These alterations in systemic hemodynamics were associated with several changes in renal hemodynamics and sodium excretion (table 2 and fig. 2 ). A decrease in renal blood flow (-18%) and an increase in renal vascular resistance (28%) and filtration fraction (16%) occurred and were accompanied by a significant decrease of -35% in urinary sodium excretion (UNaV), as glomerular filtration rate remained unchanged. A representative experiment is shown in table 3. The nine experiments with the high dose of propranolol (3 to 5 mg/kg iv) showed nearly the same changes, with the exceptions that the increase in central blood volume (18%) was greater and reached the level of statistical Intrarenal hemodynamic changes foUowing intravenous propranolol figure is the same format as figure 1. UNaV = urinary sodium excretion. significance (P < 0.05); the decrease in stroke volume was not statistically significant; and the decrease of -12% in glomerular filtration rate was significant at P< 0.05 (tables 1 and 2, figs. 1 
and 2).
In the eight experiments with controlled renal perfusion pressure there was no change in central blood volume or in glomerular filtration rate (table 1) . The statistically significant decreases in cardiac output (-20%), stroke volume (-10% ), and heart rate (-10%) and an increase in total peripheral resistance (26%) were associated with significant increases in renal vascular resistance (41%) and filtration fraction (26%) and decreases in renal blood flow (-24%) and urinary sodium excretion (-38%) (tables 1 and 2). No Sodium excretion during propranolol i one renal artery. The experimental kidi an intrarenal propranolol infusion while lateral kidney served as the control, ordinate represents the ratio in the kidney of the sodium excretion during pr fusion divided by the control sodium ex abscissa represents the same ratio in the ney. Points that fall below the 450 line no change) indicate that during propramn tration larger decreases in sodium excret in the experimental kidney than in the ney. The failure of most of the points to fl line indicates that such a unilateral effect olol in the experimental kidney was not ml/min, and that of the contr changed -16.7 ± 7.4 ml/min durin olol infusion.
Discussion
The mechanism whereby betablockade with propranolol may be with sodium retention was exam results demonstrated that intraven( istration of propranolol (0.3 to consistently decreased cardiac out rate, renal blood flow, and urina excretion and increased total peripl tance, renal vascular resistance, am fraction. The decrease in cardi RANOLOL during propranolol administration in animals ION and man has been shown to be related to the blocking of the inotropic and chronotropic effects of catecholamines (beta-adrenergic blockade). In large doses propranolol also causes cardiac depression.l 0-2 The results of the present study demonstrate that when cardiac output is primarily reduced by propranolol, the arterial pressure remains relatively constant because of an increase in total peripheral resistance. The mechanism of this increase in total peripheral resistance seems likely to be of a reflex nature since the direct effect of propranolol on the peripheral vasculature is minimal.13 14 A baroreceptor-initiated increase in sympathetic outflow to the peripheral vasculature is a potential mediator of this the administration of propranolol would be 5 mg/kg) expected to decrease hydrostatic and increase -put, heart oncotic pressures in the peritubular circulation ry sodium and thereby enhance reabsorption. These heral resis-alterations in renal hemodynamics may thus d filtration be the mechanism whereby propranolol inac output creases sodium reabsorption and decreases sodium excretion. This indirect effect of propranolol on sodium excretion by alterations in systemic and renal hemodynamics seemed most tenable since a unilateral effect on sodium excretion was not demonstrated during the intrarenal infusion of the drug. Although unilateral stimulation of renal betaadrenergic receptors with isoproterenol has been reported to decrease proximal tubular sodium reabsorption unilaterally,2' our results indicate that under the circumstances of this study renal beta-receptor blockade does not affect sodium excretion. An effect of betablockade on proximal sodium reabsorption (which does not alter sodium excretion because of adjustments in distal reabsorption) cannot, however, be excluded. Chronic oral administration as well as acute intravenous administration of propranolol to man decreases cardiac output and increases total peripheral resistance.22 Chronic propranolol administration, particularly in patients with heart disease, has also been shown to result in abnormalities of urinary sodium excretion. The results of the present study suggest that this effect of propranolol on sodium excretion may be related to the systemic effect of the drug, with reflex renal hemodynamic alterations which enhance sodium reabsorption.
The present results indicate that propranolol increases renal vascular resistance and filtration fraction as part of a systemic adjustment to a decrease in cardiac output. These intrarenal hemodynamic alterations may increase sodium reabsorption and decrease urinary sodium excretion by altering the Starling's forces in the peritubular circulation. These findings also suggest that the same mechanism may be responsible for the sodium retention associated with propranolol administration in patients with heart failure.
